Clinical Trials

200 enrolled

Esophageal Squamous Cell Carcinoma

NCT01815853 2025-07-03

Neo-CRAG

620 enrolled

Stomach Neoplasms

NCT06775652 2025-01-15

ESCC

254 enrolled

Esophageal Squamous Cell Carcinoma

NCT03381651 2024-11-18

Neo-DRATEC

147 enrolled

Esophageal Neoplasms

NCT06630481 2024-10-08

CAP with NAT

462 enrolled

Pancreatic Neoplasms

NCT06556355 2024-08-16

Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy

218 enrolled

Esophageal Neoplasms, Anastomotic Leak

NCT06261138 2024-02-15

Survival Analysis: TACE vs. Combination Therapy in HCC

279 enrolled

Carcinoma, Hepatocellular

NCT06129812 2023-11-13

An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer

1,132 enrolled

Pancreatic Neoplasms

NCT00089024 2023-09-29

Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

29 enrolled 8 charts

Pancreatic Neoplasms

NCT00049348 2023-06-15

Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Pancreatic Neoplasms

NCT01444495 2023-02-15

Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer

154 enrolled

Rectal Neoplasms

NCT05592873 2022-10-25

I-ONARC

317 enrolled

Rectal Neoplasms

NCT05496270 2022-08-11

Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer

1,509 enrolled

Rectal Neoplasms

NCT05495308 2022-08-10

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

4 enrolled

Rectal Neoplasms

NCT05339763 2022-04-21

Long Term Bowel Function Following Rectal Cancer Surgery

171 enrolled

Rectal Neoplasms, Irritable Bowel Syndrome

NCT04513457 2021-03-29

Chemotherapy for Resectable Colorectal Liver Metastases

967 enrolled

Liver Neoplasms, Colorectal Neoplasms

NCT00002883 2021-02-23

Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus

250 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00003652 2021-02-17

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

350 enrolled

Anal Canal Carcinoma, Anus Neoplasms

NCT00227747 2021-02-17

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

598 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT01107639 2020-10-20

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

297 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00003862 2020-10-19

Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer

Stomach Neoplasms

NCT04553458 2020-09-17

Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

407 enrolled

Carcinoma, Hepatocellular

NCT04027543 2020-05-29

Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）

423 enrolled

Esophageal Neoplasms, Radiation Injuries

NCT00047112 2020-03-30

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

195 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03899870 2019-04-02

Factors Predicting Recurrence in Rectal Cancer After Surgery

188 enrolled

Rectal Neoplasms, Recurrence

NCT01458717 2018-05-02

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Phase 2/3 Completed

58 enrolled

Neoplasms, Pancreatic Neoplasms, Recurrence

NCT00114231 2018-03-29

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer

90 enrolled 10 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT03469375 2018-03-27

Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer

41 enrolled

Pancreatic Neoplasms

NCT00972881 2017-10-25

EXCITE

Phase 1/2 Completed

82 enrolled

Rectal Neoplasms

NCT03151759 2017-05-12

MMP-7

77 enrolled

Rectal Neoplasms

NCT00536874 2017-03-16

Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

39 enrolled 12 charts

Pancreatic Neoplasms

NCT02984501 2016-12-07

Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer

41 enrolled

Pancreatic Neoplasms

NCT01263171 2016-09-21

COPERNICUS

60 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT01360086 2016-05-30

Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction

65 enrolled

Stomach Neoplasms

NCT00354679 2016-05-16

Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer

34 enrolled 5 charts

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00757172 2016-03-11

Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction

70 enrolled 15 charts

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00004891 2015-12-22

PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery

149 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT00084773 2015-12-22

Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer

28 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT01521702 2015-03-20

NEOPAC

2 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT00021320 2014-05-09

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

21 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00416858 2014-03-04

Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery

40 enrolled

Esophageal Neoplasms

NCT00003422 2013-12-04

Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed

1,800 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT00470184 2013-11-25

Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer

41 enrolled 8 charts

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00262808 2013-10-16

GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer

50 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00909987 2013-10-11

Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum

46 enrolled

Rectal Neoplasms

NCT01086618 2013-08-26

Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Phase 2/3 Completed

500 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00335543 2013-08-12

Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery

254 enrolled

Pancreatic Neoplasms

NCT00629863 2013-08-07

Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer

700 enrolled

Esophageal Neoplasms, Stomach Neoplasms

NCT00182611 2013-06-26

S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer

100 enrolled